Advaxis
ADXS
$0.66
Share price
19.73%
Change (1 day)
-42.22%
Change (1 year)
Categories
Advaxis (ADXS) - Cash on Hand
Cash on Hand as of December 2023 : $4.88 M
According to Advaxis's latest financial reports the company has $4.88 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Advaxis - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | $36.98 M | -12% |
| 2020-12-31 | $42.02 M | 151.27% |
| 2019-12-31 | $16.72 M | -35.91% |
| 2018-12-31 | $26.09 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | $20.13 M | 312.47% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $0.14 B | 2,876.12% | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.12 B | 2,464.71% | 🇺🇸 USA |